Skip to main content
FinSpry Logo
FinSpry
TXG logo
TXG
(NASDAQ)
10x Genomics, Inc.
$32.94-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

10x Genomics (TXG) Stock Price & Financial Analysis

10x Genomics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$32.71 - $36.59
52-Week High$35.65
52-Week Low$10.48
Open$35.33
Volume4.26M
Average Volume (3M)3.20M
Market Cap4.46B
Shares Outstanding128.29M
Price to Sales (P/S)6.98
Price to Book (P/B)5.48
EV/EBITDA43.41
Revenue (TTM)638.78M
Net Income (TTM)-22.66M
Free Cash Flow (TTM)122.18M
EPS (TTM)$-0.18
Profit Margin-3.55%
Operating Margin-6.06%
Return on Equity (ROE)-2.78%
Debt to Equity0.10
50-Day MA$25.33
200-Day MA$19.10
52-Week Change219.73%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About 10x Genomics

What is the current stock price for TXG?

As of the latest trading session, TXG stock trades at $32.94. The 52-week range is $10.48–$35.65, with a day range of $32.71–$36.59.

What is the P/E ratio for TXG?

The P/E ratio (Price-to-Earnings) for TXG is shown in the Key Statistics section. This valuation metric helps compare 10x Genomics, Inc. to industry peers.

Does TXG pay dividends?

10x Genomics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TXG?

Based on 12 analysts, the consensus for TXG is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TXG?

10x Genomics's market capitalization is $4.23B, classifying it as a mid-cap company. 10x Genomics operates in the Healthcare sector within the Health Information Services industry.